{2 (thyrotropin alfa 0.9 MG Injection [Thyrogen]) } Pack [Thyrogen Kit (0.9 MG Vial)] — RxCUI 2554805
RxNorm drug concept · Brand name pack
RxCUI 2554805
Brand name pack · BPCK
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2554805
Official name{2 (thyrotropin alfa 0.9 MG Injection [Thyrogen]) } Pack [Thyrogen Kit (0.9 MG Vial)]
Concept typeBrand name pack (BPCK)
RxNorm statusCurrent RxNorm concept
Also known asThyrogen Kit (0.9 MG Vial)
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)488 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How {2 (thyrotropin alfa 0.9 MG Injection [Thyrogen]... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
{2 (thyrotropin alfa 0.9 MG Injection [Thyrogen]) } Pack [Thyrogen Kit (0.9 MG Vial)]
RxCUI 2554805 Brand name pack · BPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Thyrotropin alfa
4952IN
-
Thyrotropin alfa
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Thyrogen
2166574BN
-
Thyrogen
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Thyrotropin alfa Injection
2166571SCDF -
Thyrotropin alfa Injectable Product
2166570SCDG -
Thyrotropin alfa Injection [Thyrogen]
2166576SBDF -
Thyrogen Injectable Product
2166577SBDG -
Pack
746839DF -
Injectable Product
1151126DFG
-
Thyrotropin alfa Injection
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Thyrotropin alfa 0.9 MG Injection
2554801SCD -
Thyrotropin alfa 0.9 MG
2554800SCDC -
Thyrotropin alfa 0.9 MG Injection [Thyrogen]
2554804SBD -
Thyrotropin alfa 0.9 MG [Thyrogen]
2554803SBDC
-
Thyrotropin alfa 0.9 MG Injection
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
-
{2 (thyrotropin alfa 0.9 MG Injection) } Pack
2554802GPCK
-
{2 (thyrotropin alfa 0.9 MG Injection) } Pack
Showing up to 8 concepts per family — 13 of 13 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Thyrotropin alfa 0.9 MG Injection
SCD · 2554801 -
{2 (thyrotropin alfa 0.9 MG Injection) } Pack
GPCK · 2554802 -
Thyrotropin alfa 0.9 MG
SCDC · 2554800 -
Thyrotropin alfa Injection
SCDF · 2166571 -
Thyrotropin alfa Injectable Product
SCDG · 2166570
Brand-Name Concepts
-
Thyrotropin alfa 0.9 MG Injection [Thyrogen]
SBD · 2554804 -
Thyrotropin alfa 0.9 MG [Thyrogen]
SBDC · 2554803 -
Thyrotropin alfa Injection [Thyrogen]
SBDF · 2166576 -
Thyrogen Injectable Product
SBDG · 2166577 -
Thyrogen
BN · 2166574
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2554805 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 58468-0030-02 | 2 VIAL, SINGLE-DOSE in 1 CARTON (58468-0030-2) / 1 mL in 1... | Thyrogen | Genzyme Corporation | 1998-11-30 |
Observed labelers:
Genzyme Corporation (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3240 | Thyrotropin injection | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.